Metabolic impact of current therapeutic strategies in Polycystic Ovary Syndrome: a preliminary study.

Purpose: To investigate the metabolic impact of currently used therapies in polycystic ovary syndrome (PCOS).

Methods: This is an observational, retrospective and transversal protocol. A small cohort of 133 patients, aged 14-48 years, diagnosed with PCOS was divided into four experimental groups: 1) untreated PCOS patients (n = 51); 2) PCOS patients treated with one of the following therapies (n = 82): a) combined oral contraceptives (COC, n = 35); b) metformin (n = 11); and c) inositols (n = 36).